Top ONE Network news of 2020

Top ONE Network news of 2020

Comprehensive Ophthalmology, Glaucoma, Neuro-Ophthalmology/Orbit, Oculoplastics/Orbit, Retina/Vitreous

From the COVID-19 pandemic to brolucizumab safety concerns, here’s a look at the year’s most-viewed clinical news stories and Editors’ Choice coverage.


1. Coronavirus kills Chinese whistleblower ophthalmologist

By Keng Jin Lee

Li Wenliang, MD, an ophthalmologist working in Wuhan where the coronavirus epidemic originated, has died.

Feb 10, 2020

2. Update: Brolucizumab’s safety under review

By Kanaga Rajan

Novartis has launched a safety review of their new anti-VEGF agent brolucizumab (Beovu) following reports of possible unintended side effects after the drug was approved last October.

March 11, 2020

3. First blepharoptosis drug gains FDA approval

By Kanaga Rajan

The FDA has cleared a novel ophthalmic solution of oxymetazoline hydrochloride (Upneeq) for acquired blepharoptosis, making it the only approved therapy for the condition.

July 14, 2020

4. Biodegradable bimatoprost implant gains FDA approval

By Kanaga Rajan

Allergan’s bimatoprost implant (Durysta) is now the first approved intracameral, sustained-release therapy for lowering IOP in patients with open-angle glaucoma or ocular hypertension.

March 06, 2020

5. FDA issues alert on intraocular compounded moxifloxacin

By Kanaga Rajan

The FDA has received case reports of toxic anterior segment syndrome (TASS) following intraocular administration of compounded drugs using moxifloxacin as a bulk drug substance. 

Aug 13, 2020

Editors’ Choice

1. What are the ocular symptoms of COVID-19?

By Nandini Venkateswaran, MD

This study presents information found on ocular signs and symptoms in patients infected with SARS-CoV-2.

April 15, 2020

2. Cranial neuropathy soon after COVID-19 onset

By Danah Albreiki, MBBS

This study describes 2 patients who developed cranial neuropathies within days of presenting with SARS-CoV-2-related respiratory symptoms.

June 09, 2020

3. Conjunctivitis could be the only presenting sign and symptom of COVID-19

By Renée Solomon, MD

This case study details 5 patients with nonremitting conjunctivitis that was the sole presenting sign and symptom of COVID-19.

June 17, 2020

4. Could the eye be an entry point for SARS-CoV-2?

By Damien M. Luviano, MD

The authors investigated whether ocular surface cells possess the key factors required for cellular susceptibility to SARS-CoV-2, the virus that causes COVID-19.

July 07, 2020

5. Case study links COVID-19 to follicular conjunctivitis

By Rahul T. Pandit, MD

The authors report the ocular characteristics and presence of viral RNA in a patient with COVID-19.

May 01, 2020